|Mr. Marcus Wolfinger||Chairman of Board of Management & CEO||577k||N/A||1967|
|Dr. Robert Siegle||Director of Fin. & HR and Member of Board of Management||469k||N/A||1967|
|Dr. Claus Vielsack||Director of Product Devel. & Member of Board of Management||405k||N/A||1967|
|Mr. Hermann Leistner||Founder & Advisor||N/A||N/A||1946|
|Sandra Eberle||Head of Investor Relations||N/A||N/A||N/A|
STRATEC SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates in three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to STRATEC SE in December 2018. STRATEC SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Stratec SE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.